It has long been known that dental and orthopedic devices and materials may have a negative impact on certain patients. In this interview, integrative medical expert and immunologist Russell Jaffe, MD, PhD, CCN, explains how to accurately identify immunocompatibility and risk for patients undergoing dental and/or orthopedic procedures. Jaffe explains how reactivity testing can be used to create more effective and less dangerous treatment plans for sensitive patients.
Approximate listening time: 30 minutes
Continuing Education Credits Available
This podcast interview qualifies for 0.5 general continuing education (CE) units. The Oregon Board of Naturopathic Medicine has approved this educational content for 0.5 “general” CE units for naturopathic physicians. Naturopathic physicians licensed in any U.S. state except California may obtain general CE by listening to this podcast and completing a 10-question test on the material contained within the clinical topic. Click the button below to take the test for FREE, thanks to an educational grant from Perque Integrative Health. Upon successful completion, you will receive an email confirming you passed. This CE approval may also qualify for the CE requirements of other practitioner types.
About the Expert
Russell Jaffe, MD, PhD, CCN, CEO and Chairman of PERQUE Integrative Health, is one of the pioneers of integrative and regenerative medicine. Since inventing the world’s first single-step amplified (ELISA) procedure in 1984, a process for measuring and monitoring all delayed allergies, Jaffe has continually sought new ways to help speed the transition from our current healthcare system’s symptom-reactive model to a more functionally integrated, effective and compassionate system. PIH is the outcome of years of Jaffe’s scientific research. It brings to market three decades of rethinking safer, more effective, novel and proprietary dietary supplements, supplement delivery systems, diagnostic testing, and validation studies.